← Back to the feed

CUTISS AG

History from 13 Mar 2017

UID

CHE-233.237.662

Legal form

AG

Canton

ZH

Founded

13 Mar 2017

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 27 Jul 2022 · legal date 16 Jun 2022

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   266’223.10 → 287’846.30

   Shares

   2’662’231 → 2’878’463

   New shares, % of post-step shares

   7.5% (216’232 new)

   Aktienkapital neu: CHF 287'846.30 [bisher: CHF 266'223.10]. Liberierung Aktienkapital neu: CHF 287'846.30 [bisher: CHF 266'223.10]. Aktien neu: 2'878'463 Namenaktien zu CHF 0.10 [bisher: 2'662'231 Namenaktien zu CHF 0.10]. Kapitalerhöhung aus genehmigtem Aktienkapital. Die Gesellschaft hat mit Beschluss vom 16.06.2022 die mit Beschluss vom 26.05.2020 eingeführte Bestimmung betreffend bedingter Kapitalerhöhung gemäss näherer Umschreibung in den Statuten geändert.

   SHAB HR02-1005529744 ↗

2. SHAB published 3 Mar 2023 · legal date 10 Feb 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   287’846.30 → 317’326.80

   Shares

   2’878’463 → 3’173’268

   New shares, % of post-step shares

   9.3% (294’805 new)

   Aktienkapital neu: CHF 317'326.80 [bisher: CHF 287'846.30]. Liberierung Aktienkapital neu: CHF 317'326.80 [bisher: CHF 287'846.30]. Aktien neu: 3'173'268 Namenaktien zu CHF 0.10 [bisher: 2'878'463 Namenaktien zu CHF 0.10].

   SHAB HR02-1005691914 ↗

3. SHAB published 5 Jun 2023 · legal date 26 May 2023

   Capital increase

   Not assessed

   Issued from conditional capital

   Nominal capital

   317’326.80 → 321’030.90

   Shares

   3’173’268 → 3’210’309

   New shares, % of post-step shares

   1.2% (37’041 new)

   Aktienkapital neu: CHF 321'030.90 [bisher: CHF 317'326.80]. Liberierung Aktienkapital neu: CHF 321'030.90 [bisher: CHF 317'326.80]. Aktien neu: 3'210'309 Namenaktien zu CHF 0.10 [bisher: 3'173'268 Namenaktien zu CHF 0.10].

   SHAB HR02-1005759638 ↗

4. SHAB published 4 Apr 2024 · legal date 21 Mar 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   321’030.90 → 376’284.40

   Shares

   3’210’309 → 3’762’844

   New shares, % of post-step shares

   14.7% (552’535 new)

   Share classes

   3’210’309 × CHF 0.10 · 552’535 × CHF 0.10 Vorzugsaktien

   Aktienkapital neu: CHF 376'284.40 [bisher: CHF 321'030.90]. Liberierung Aktienkapital neu: CHF 376'284.40 [bisher: CHF 321'030.90]. Aktien neu: 3'210'309 Namenaktien zu CHF 0.10 und 552'535 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 3'210'309 Namenaktien zu CHF 0.10]. Die Gesellschaft hat mit Beschluss vom 21.03.2024 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

   SHAB HR02-1006000113 ↗

5. SHAB published 4 Apr 2024 · legal date 21 Mar 2024

   Capital band adopted

   SHAB HR02-1006000113 ↗

6. SHAB published 10 Sep 2024 · legal date 29 Aug 2024

   Capital increase

   Not assessed

   Issued from conditional capital

   Nominal capital

   376’284.40 → 383’901.30

   Shares

   3’762’844 → 3’839’013

   New shares, % of post-step shares

   2.0% (76’169 new)

   Share classes

   3’286’478 × CHF 0.10 · 552’535 × CHF 0.10 Vorzugsaktien

   Aktienkapital neu: CHF 383'901.30 [bisher: CHF 376'284.40]. Liberierung Aktienkapital neu: CHF 383'901.30 [bisher: CHF 376'284.40]. Aktien neu: 3'286'478 Namenaktien zu CHF 0.10 und 552'535 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 3'210'309 Namenaktien zu CHF 0.10 und 552'535 Namenaktien zu CHF 0.10 (Vorzugsaktien)].

   SHAB HR02-1006125531 ↗

7. SHAB published 16 Oct 2024 · legal date 25 Sep 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   383’901.30 → 385’951.20

   Shares

   3’839’013 → 3’859’512

   New shares, % of post-step shares

   0.5% (20’499 new)

   Share classes

   3’286’478 × CHF 0.10 · 573’034 × CHF 0.10 Vorzugsaktien

   Aktienkapital neu: CHF 385'951.20 [bisher: CHF 383'901.30]. Liberierung Aktienkapital neu: CHF 385'951.20 [bisher: CHF 383'901.30]. Aktien neu: 3'286'478 Namenaktien zu CHF 0.10 und 573'034 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 552'535 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 3'286'478 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   SHAB HR02-1006155049 ↗

8. SHAB published 25 Aug 2025 · legal date 14 Aug 2025

   Capital increase

   ●●●Confirmed round

   Paid in cash

   Nominal capital

   385’951.20 → 457’469.90

   Shares

   3’859’512 → 4’574’699

   New shares, % of post-step shares

   15.6% (715’187 new)

   Share classes

   3’820’103 × CHF 0.10 · 754’596 × CHF 0.10 Vorzugsaktien

   Aktienkapital neu: CHF 457'469.90 [bisher: CHF 385'951.20]. Liberierung Aktienkapital neu: CHF 457'469.90 [bisher: CHF 385'951.20]. Aktien neu: 3'820'103 Namenaktien zu CHF 0.10 und 754'596 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 3'286'478 Namenaktien zu CHF 0.10 und 573'034 Namenaktien zu CHF 0.10 (Vorzugsaktien)]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes. [bisher: Die Gesellschaft hat mit Beschluss vom 21.03.2024 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.]

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006415440 ↗

9. SHAB published 25 Aug 2025 · legal date 14 Aug 2025

   Capital band adopted

   SHAB HR02-1006415440 ↗

10. Announced 10 Sep 2025

    Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

11. SHAB published 13 Apr 2026 · legal date 26 Mar 2026

    Capital increase

    ●●○Likely financing

    Paid in cash

    Nominal capital

    457’469.90 → 473’489.10

    Shares

    4’574’699 → 4’734’891

    New shares, % of post-step shares

    3.4% (160’192 new)

    Share classes

    3’820’103 × CHF 0.10 · 914’788 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 473'489.10 [bisher: CHF 457'469.90]. Liberierung Aktienkapital neu: CHF 473'489.10 [bisher: CHF 457'469.90]. Aktien neu: 3'820'103 Namenaktien zu CHF 0.10 und 914'788 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 754'596 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 3'820'103 Namenaktien zu CHF 0.10].

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006622373 ↗

12. SHAB published 11 Sep 2026 · legal date 18 Aug 2026

    Capital increase

    ○○○Capital increased

    Issued from conditional capital

    Nominal capital

    473’489.10 → 487’739.70

    Shares

    4’734’891 → 4’877’397

    New shares, % of post-step shares

    2.9% (142’506 new)

    Share classes

    3’961’836 × CHF 0.10 · 915’561 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 487'739.70 [bisher: CHF 473'489.10]. Liberierung Aktienkapital neu: CHF 487'739.70 [bisher: CHF 473'489.10]. Aktien neu: 3'961'836 Namenaktien zu CHF 0.10 und 915'561 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 914'788 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 3'820'103 Namenaktien zu CHF 0.10].

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5
    • Shares issued out of conditional capital, as when options are exercised.−1.0

    Classifier score 0.06 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006753995 ↗

Published by 8 Oct 2026